Feng Yin Selected Research

Teratocarcinoma

1/2019	Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem-Like Cells In Vivo.
1/2018	New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells.
7/2017	Black phosphorus quantum dot based novel siRNA delivery systems in human pluripotent teratoma PA-1 cells.
1/2017	In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feng Yin Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 06/2010
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2015
4	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2012
4	Adenocarcinoma 04/2021 - 01/2015
4	Carcinoma (Carcinomatosis) 01/2019 - 10/2012
4	Teratocarcinoma 01/2019 - 01/2017
4	Glioblastoma (Glioblastoma Multiforme) 12/2016 - 05/2012
3	Wounds and Injuries (Trauma) 01/2022 - 01/2014
3	Osteoarthritis 01/2022 - 01/2017
3	Inflammation (Inflammations) 11/2021 - 01/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 01/2018 - 11/2017
2	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2022
2	COVID-19 07/2021 - 12/2020
2	Infections 07/2021 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 12/2018 - 08/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2016 - 02/2016
2	Atrial Fibrillation 08/2015 - 01/2015
2	Glioma (Gliomas) 08/2014 - 08/2009
2	Fistula 04/2004 - 06/2003
2	Cardiomegaly (Heart Hypertrophy) 04/2004 - 08/2003
2	Body Weight (Weight, Body) 08/2003 - 06/2003
1	Torticollis (Wryneck) 10/2022
1	Triple Negative Breast Neoplasms 02/2022
1	Bone Resorption 01/2022
1	Postoperative Pain 01/2022
1	Osteoporosis 01/2022
1	Shock 04/2021
1	Polyps 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021

Drug/Important Bio-Agent (IBA)

10	Peptides (Polypeptides)IBA 01/2021 - 04/2016
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2010
9	Small Interfering RNA (siRNA)IBA 10/2019 - 01/2015
6	Pharmaceutical PreparationsIBA 09/2019 - 01/2015
5	Biological ProductsIBA 01/2021 - 04/2016
3	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 10/2016
3	CholesterolIBA 07/2021 - 08/2015
3	Indicators and Reagents (Reagents)IBA 07/2021 - 04/2019
3	GoldIBA 03/2020 - 01/2015
3	Messenger RNA (mRNA)IBA 12/2016 - 08/2014
2	VimentinIBA 01/2022 - 03/2020
2	Cadherins (E-Cadherin)IBA 01/2022 - 10/2018
2	MetalsIBA 04/2021 - 12/2015
2	IntegrinsIBA 08/2020 - 04/2016
2	Long Noncoding RNAIBA 01/2020 - 12/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2019
2	EnzymesIBA 05/2018 - 10/2013
2	MicroRNAs (MicroRNA)IBA 05/2018 - 08/2014
2	Antimicrobial PeptidesIBA 01/2018 - 01/2016
2	LigandsIBA 01/2018 - 01/2015
2	PolymersIBA 07/2017 - 01/2015
2	PolyelectrolytesIBA 07/2017 - 01/2015
2	Histones (Histone)IBA 10/2016 - 01/2014
2	C-Reactive ProteinIBA 08/2015 - 01/2015
2	Atorvastatin (Lipitor)FDA Link 08/2015 - 01/2015
2	Oncogene Proteins (Oncogene Protein)IBA 05/2013 - 06/2010
2	Phosphotransferases (Kinase)IBA 10/2012 - 06/2010
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2004 - 06/2003
1	Fibroins (Fibroin)IBA 01/2022
1	CollagenIBA 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022
1	icariinIBA 01/2022
1	enasidenibIBA 01/2022
1	Cathepsin KIBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Amino Acids FDA Link 01/2022
1	ivosidenibIBA 01/2022
1	Ubiquitin-Specific ProteasesIBA 01/2022
1	InterleukinsIBA 11/2021
1	ProteomeIBA 07/2021
1	Complement System Proteins (Complement)IBA 07/2021
1	SilicatesIBA 04/2021
1	olivineIBA 04/2021
1	Dihydroorotate DehydrogenaseIBA 01/2021
1	pyrimidineIBA 01/2021
1	AcidsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	delta-1-pyrroline-5-carboxylateIBA 01/2021
1	Apoptosis Regulatory ProteinsIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 12/2020
1	Lipoproteins (Lipoprotein)IBA 12/2020
1	Monoclonal AntibodiesIBA 12/2020
1	Cell Surface ReceptorsIBA 12/2020
1	Polysaccharides (Glycans)IBA 08/2020
1	Stimuli Responsive PolymersIBA 08/2020

Therapy/Procedure

19	Therapeutics 01/2021 - 04/2004
5	Drug Therapy (Chemotherapy) 08/2020 - 01/2015
3	Quantum Dots (Quantum Dot) 07/2017 - 01/2015
3	Transplantation 08/2016 - 08/2009
2	Adjuvant Chemotherapy 04/2021 - 12/2018
2	Intraperitoneal Injections 01/2019 - 08/2003
1	Deep Brain Stimulation 10/2022
1	Consolidation Chemotherapy 01/2022